Publication|Articles|April 10, 2026
- Pharmaceutical Executive: April 2026
- Volume 46
- Issue 3
Pharmaceutical Executive: April 2026 Interactive Digital Edition
View the Pharmaceutical Executive April 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Where the True Bottlenecks Exist at FDA for Clinical Trials
2
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
3
argenx Acquires Forte Biosciences for $2.2 Billion
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5
